For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220610:nRSJ5078Oa&default-theme=true
RNS Number : 5078O Inspiration Healthcare Group PLC 10 June 2022
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Exercise of options and Total Voting Rights
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company announces that, pursuant to the exercise of options at nil cost under
the Inspiration Healthcare Group plc Long Term Incentive Plan (the "LTIP") by
an employee of the Group, a total of 6,250 new ordinary shares of 10p each in
the Company ("New Ordinary Shares") have been issued and allotted by the
Company.
The Company further announces that it has received notice of the exercise of
options in relation to employee share options over 2,909 New Ordinary Shares
issued under the Company's Sharesave Scheme.
Application has been made for an aggregate of 9,159 New Ordinary Shares to be
admitted to AIM ("Admission") and such Admission is expected to become
effective at 8.00am on or around 15 June 2022. The New Ordinary Shares shall
rank pari passu with the existing Ordinary Shares in issue.
Total Voting Rights
For the purpose of the Disclosure Guidance and Transparency Rules of the FCA,
following the above issue of New Ordinary Shares, the issued share capital of
the Company will comprise 68,130,606 Ordinary Shares. The above figure may be
used by shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or a change
to their interest in, the Company, under the FCA's Disclosure Guidance and
Transparency Rules.
Enquiries:
Inspiration Healthcare Group plc Tel: 01455 840555
Neil Campbell, Chief Executive Officer
Jon Ballard, Chief Financial Officer
Nominated Adviser & Broker Tel: 0207 397 8900
Cenkos Securities plc
Stephen Keys
Mark Connelly
Katy Birkin
Dan Hodkinson
Cadogan Tel: 07771 713608
PR
Alex Walters
alex.walters@cadoganpr.com (mailto:alex.walters@cadoganpr.com)
About Inspiration Healthcare Group
www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk/)
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology
for use in critical care & operating theatres. The Company provides
high-quality, innovative products to patients around the world which help to
improve patient outcomes, and it actively invests in innovative product
opportunities and disruptive technologies.
The Group currently consists of three companies: Inspiration Healthcare Ltd,
SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal
intensive care and operating theatre equipment around the work through a
network of distributors into over 75 countries. Products range from highly
sophisticated capital equipment through to single use disposables all that can
help improve outcomes of extremely sick patients.
In the UK and Ireland the Group offers direct sales for most of its products
supported by Technical Service offering on site and return to base repair and
maintenance along with 24/7 emergency hire of equipment and long term lease
arrangements for its own brand products. The Group also acts as a
distributor for 3(rd) party companies that wish to access the NHS using the
Group's sales and service expertise and knowledge of the NHS
The Group invests in growth through Research and Development holding numerous
patents on its technology and has strong links with academic Key Opinion
Leaders around the world and supports clinical research in the field of
neonatal intensive care.
Further information on Inspiration Healthcare Group plc can be seen
at www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCURVARUSUNAAR